Federal Register / Vol. 90, No. 22 / Tuesday, February 4, 2025 / Notices 8937 

https://www.federalreserve.gov/foia/ 

request.htm. Interested persons may 

express their views in writing on the 

standards enumerated in the BHC Act 

(12 U.S.C. 1842(c)). 

Comments received are subject to 

public disclosure. In general, comments 

received will be made available without 

change and will not be modified to 

remove personal or business 

information including confidential, 

contact, or other identifying 

information. Comments should not 

include any information such as 

confidential information that would not 

be appropriate for public disclosure. 

Comments regarding each of these 

applications must be received at the 

Reserve Bank indicated or the offices of 

the Board of Governors, Ann E. 

Misback, Secretary of the Board, 20th 

Street and Constitution Avenue NW, 

Washington, DC 20551–0001, not later 

than March 6, 2025. 

A. Federal Reserve Bank of Boston 

(Prabal Chakrabarti, Executive Vice 

President) 600 Atlantic Avenue, Boston, 

Massachusetts 02210–2204. Comments 

can also be sent electronically to 

BOS.SRC.Applications.Comments@

bos.frb.org: 

1. Independent Bank Corp., Rockland, 

Massachusetts; to acquire Enterprise 

Bancorp, Inc., and thereby indirectly 

acquire Enterprise Bank and Trust 

Company, both of Lowell, 

Massachusetts. 

B. Federal Reserve Bank of Dallas 

(Karen Smith, Assistant Vice President, 

Mergers & Acquisitions and 

Enforcement) 2200 North Pearl Street, 

Dallas, Texas 75201–2272. Comments 

can also be sent electronically to 

Comments.applications@dal.frb.org: 

1. Community Bank Holdings of 

Texas, Inc., Corsicana, Texas; to acquire 

CapTex Bancshares, Inc., and thereby 

indirectly acquire CapTex Bank, both of 

Fort Worth, Texas. 

Board of Governors of the Federal Reserve 

System. 

Michele Taylor Fennell, 

Associate Secretary of the Board. 

[FR Doc. 2025–02203 Filed 2–3–25; 8:45 am] 

BILLING CODE 6210–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–7077–N2] 

Announcement of the Advisory Panel 

on Outreach and Education (APOE) 

Virtual Meeting; Cancellation of the 

February 6, 2025, Virtual Meeting 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), Health and 

Human Services (HHS). 

ACTION: Notice. 

SUMMARY: This notice announces the 

cancellation of the February 6, 2025, 

virtual public meeting of the Advisory 

Panel on Outreach and Education 

(APOE) (the Panel) that was announced 

in the January 10, 2025, Federal 

Register (90 FR 2003 through 2005). 

CMS will publish a notice in the 

Federal Register announcing the date 

on which the next meeting of the APOE 

will take place no less than 15 calendar 

days before the meeting date. The 

meeting will be open to the public in 

accordance with the Federal Advisory 

Committee Act (FACA) (Pub. L. 92– 

463), as amended (5 U.S.C. Appendix 2). 

FOR FURTHER INFORMATION CONTACT: 

Hailey Gutzmer, Acting Designated 

Federal Official, Office of 

Communications, Centers for Medicare 

& Medicaid Services, 200 Independence 

Avenue SW, Mailstop 315D.02, 

Washington, DC 20201, 410–786–1307, 

or via email at APOE@cms.hhs.gov. 

Additional information about the 

APOE is available at: https://

www.cms.gov/Regulations-andGuidance/Guidance/FACA/APOE. Press 

inquiries are handled through the CMS 

Press Office at (202) 690–6145. 

The Acting Administrator of CMS, Jeff 

Wu, having reviewed and approved this 

document, authorizes Chyana 

Woodyard, who is the Federal Register 

Liaison, to electronically sign this 

document for purposes of publication in 

the Federal Register. 

Chyana Woodyard, 

Federal Register Liaison, Centers for Medicare 

& Medicaid Services. 

[FR Doc. 2025–02215 Filed 2–3–25; 8:45 am] 

BILLING CODE 4120–01–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation No. 337–TA–1390] 

Certain Capacitive Discharge Ignition 

Systems, Components Thereof, and 

Products Containing the Same; Notice 

of Request for Submissions on the 

Public Interest 

AGENCY: U.S. International Trade 

Commission. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that on 

January 28, 2025, the presiding 

administrative law judge (‘‘ALJ’’) issued 

an Initial Determination on Violation of 

Section 337. The ALJ also issued a 

Recommended Determination on 

remedy and bonding should a violation 

be found in the above-captioned 

investigation. The Commission is 

soliciting submissions on public interest 

issues raised by the recommended relief 

should the Commission find a violation. 

This notice is soliciting comments from 

the public and interested government 

agencies only. 

FOR FURTHER INFORMATION CONTACT: 

Namo Kim, Esq., Office of the General 

Counsel, U.S. International Trade 

Commission, 500 E Street SW, 

Washington, DC 20436, telephone (202) 

205–3459. Copies of non-confidential 

documents filed in connection with this 

investigation may be viewed on the 

Commission’s electronic docket (EDIS) 

at https://edis.usitc.gov. For help 

accessing EDIS, please email 

EDIS3Help@usitc.gov. General 

information concerning the Commission 

may also be obtained by accessing its 

internet server at https://www.usitc.gov. 

Hearing-impaired persons are advised 

that information on this matter can be 

obtained by contacting the 

Commission’s TDD terminal on (202) 

205–1810. 

SUPPLEMENTARY INFORMATION: Section 

337 of the Tariff Act of 1930 provides 

that, if the Commission finds a 

violation, it shall exclude the articles 

concerned from the United States 

unless, after considering the effect of 

such exclusion upon the public health 

and welfare, competitive conditions in 

the United States economy, the 

production of like or directly 

competitive articles in the United 

States, and United States consumers, it 

finds that such articles should not be 

excluded from entry. (19 U.S.C. 

1337(d)(1)). A similar provision applies 

to cease and desist orders. (19 U.S.C. 

1337(f)(1)). 

The Commission is soliciting 

submissions on public interest issues 


lotter on DSK11XQN23PROD with NOTICES1
8938 Federal Register / Vol. 90, No. 22 / Tuesday, February 4, 2025 / Notices 

raised by the recommended relief 

should the Commission find a violation, 

specifically: a limited exclusion order 

directed to certain capacitive discharge 

ignition systems, components thereof, 

and products containing the same 

imported, sold for importation, and/or 

sold after importation by respondents 

MOTORTECH GmbH and MOTORTECH 

Americas, LLC; and cease and desist 

orders directed to MOTORTECH 

Americas, LLC. Parties are to file public 

interest submissions pursuant to 19 CFR 

210.50(a)(4). 

The Commission is interested in 

further development of the record on 

the public interest in this investigation. 

Accordingly, members of the public and 

interested government agencies are 

invited to file submissions of no more 

than five (5) pages, inclusive of 

attachments, concerning the public 

interest in light of the ALJ’s 

Recommended Determination on 

Remedy and Bonding issued in this 

investigation on January 28, 2025. 

Comments should address whether 

issuance of the recommended remedial 

orders in this investigation, should the 

Commission find a violation, would 

affect the public health and welfare in 

the United States, competitive 

conditions in the United States 

economy, the production of like or 

directly competitive articles in the 

United States, or United States 

consumers. 

In particular, the Commission is 

interested in comments that: 

(i) explain how the articles potentially 

subject to the recommended remedial 

orders are used in the United States; 

(ii) identify any public health, safety, 

or welfare concerns in the United States 

relating to the recommended orders; 

(iii) identify like or directly 

competitive articles that complainant, 

its licensees, or third parties make in the 

United States which could replace the 

subject articles if they were to be 

excluded; 

(iv) indicate whether complainant, 

complainant’s licensees, and/or thirdparty suppliers have the capacity to 

replace the volume of articles 

potentially subject to the recommended 

orders within a commercially 

reasonable time; and 

(v) explain how the recommended 

orders would impact consumers in the 

United States. 

Written submissions must be filed no 

later than by close of business on 

February 27, 2025. 

Persons filing written submissions 

must file the original document 

electronically on or before the deadlines 

stated above pursuant to 19 CFR 

210.4(f). Submissions should refer to the 

investigation number (‘‘Inv. No. 337– 

TA–1390’’) in a prominent place on the 

cover page and/or the first page. (See 

Handbook for Electronic Filing 

Procedures, https://www.usitc.gov/ 

secretary/fed_reg_notices/rules/ 

handbook_on_electronic_filing.pdf). 

Persons with questions regarding filing 

should contact the Secretary (202–205– 

2000). 

Any person desiring to submit a 

document to the Commission in 

confidence must request confidential 

treatment by marking each document 

with a header indicating that the 

document contains confidential 

information. This marking will be 

deemed to satisfy the request procedure 

set forth in Rules 201.6(b) and 

210.5(e)(2) (19 CFR 201.6(b) & 

210.5(e)(2)). Documents for which 

confidential treatment by the 

Commission is properly sought will be 

treated accordingly. Any non-party 

wishing to submit comments containing 

confidential information must serve 

those comments on the parties to the 

investigation pursuant to the applicable 

Administrative Protective Order. A 

redacted non-confidential version of the 

document must also be filed 

simultaneously with any confidential 

filing and must be served in accordance 

with Commission Rule 210.4(f)(7)(ii)(A) 

(19 CFR 210.4(f)(7)(ii)(A)). All 

information, including confidential 

business information and documents for 

which confidential treatment is properly 

sought, submitted to the Commission for 

purposes of this investigation may be 

disclosed to and used: (i) by the 

Commission, its employees and Offices, 

and contract personnel (a) for 

developing or maintaining the records 

of this or a related proceeding, or (b) in 

internal investigations, audits, reviews, 

and evaluations relating to the 

programs, personnel, and operations of 

the Commission including under 5 

U.S.C. appendix 3; or (ii) by U.S. 

government employees and contract 

personnel, solely for cybersecurity 

purposes. All contract personnel will 

sign appropriate nondisclosure 

agreements. All nonconfidential written 

submissions will be available for public 

inspection on EDIS. 

This action is taken under the 

authority of section 337 of the Tariff Act 

of 1930, as amended (19 U.S.C. 1337), 

and in Part 210 of the Commission’s 

Rules of Practice and Procedure (19 CFR 

part 210). 

By order of the Commission. 

Issued: January 30, 2025. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2025–02206 Filed 2–3–25; 8:45 am] 

BILLING CODE 7020–02–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation No. 337–TA–1368] 

Certain Vaporizer Devices, Cartridges 

Used Therewith, and Components 

Thereof; Notice of Final Determination 

Finding a Violation of Section 337; 

Issuance of a Limited Exclusion Order 

and Cease and Desist Orders; 

Termination of Investigation 

AGENCY: U.S. International Trade 

Commission. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that 

the U.S. International Trade 

Commission has determined that 

respondents (1) NJOY, LLC of Phoenix, 

Arizona; (2) NJOY Holdings, Inc. of 

Scottsdale, Arizona; (3) Altria Group, 

Inc. of Richmond, Virginia; (4) Altria 

Group Distribution Company of 

Richmond, Virginia; and (5) Altria 

Client Services LLC of Richmond, 

Virginia (collectively, ‘‘NJOY’’) have 

violated section 337, by importing, 

selling for importation, or selling within 

the United States after importation 

certain vaporizer devices, cartridges 

used therewith, and components thereof 

that infringe claims 1 and 15 of U.S. 

Patent No. 11,134,722 (‘‘the ’722 

patent’’), claims 1 and 8 of U.S. Patent 

No. 11,606,981 (‘‘the ’981 patent’’), 

claims 27 and 32 of U.S. Patent No. 

10,130,123 (‘‘the ’123 patent’’), and 

claims 1 and 4 of U.S. Patent No. 

10,709,173 (‘‘the ’173 patent’’). The 

Commission has determined that the 

appropriate remedies are a limited 

exclusion order (‘‘LEO’’) against NJOY’s 

infringing products and cease and desist 

orders (‘‘CDOs’’) against each of the 

NJOY respondents. The Commission has 

also determined to impose no bond 

(zero percent bond) for importations of 

the excluded articles imported during 

the period of Presidential review. This 

investigation is hereby terminated. 

FOR FURTHER INFORMATION CONTACT: 

Richard P. Hadorn, Esq., Office of the 

General Counsel, U.S. International 

Trade Commission, 500 E Street SW, 

Washington, DC 20436, telephone (202) 

205–3179. Copies of non-confidential 

documents filed in connection with this 

investigation may be viewed on the 

Commission’s electronic docket (EDIS) 

at https://edis.usitc.gov. For help 


lotter on DSK11XQN23PROD with NOTICES1